Legal Representation
Attorney
Kathryn Starshak
USPTO Deadlines
Next Deadline
1395 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-09-05)
Due Date
September 05, 2029
Grace Period Ends
March 05, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
14 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 5, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Sep 5, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 20, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 20, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 31, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 18, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 16, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 16, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 16, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 16, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 7, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 13, 2022 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Aug 12, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 25, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 040
Contract manufacturing services of biopharmaceuticals, namely, antibodies and recombinant proteins utilizing mammalian cell culture, to the order and/or specification of others
First Use Anywhere:
Jul 1, 2019
First Use in Commerce:
Jul 1, 2019
Class 042
Process development for others, namely, technological research in the field of manufacturing processes for others in the field of biopharmaceuticals, namely, antibodies and recombinant proteins utilizing mammalian cell culture; Process development for others, namely, product research and development in the field of biopharmaceuticals, namely, antibodies and recombinant proteins utilizing mammalian cell culture
First Use Anywhere:
Jul 1, 2019
First Use in Commerce:
Jul 1, 2019
Additional Information
Design Mark
The mark consists of the words "AVID BIOSERVICES" in a stacked formation with two wave lines extended to the right from the letter "D" in "AVID". The words "WHERE COLLABORATION, QUALITY AND RELIABILITY MEET." are below.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
AVID BIO SERVICES WHERE COLLABORATION QUALITY AND RELIABILITY MEET
Classification
International Classes
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSERVICES"